Exercise-induced bronchospasm: evaluation of metaproterenol.
D000336:Aerosols; D000818:Animals; D001249:Asthma / Q000150:complications; D001986:Bronchial Spasm / Q000150:complications / Q000517:prevention & control*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002648:Child; D006168:Guinea Pigs; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use*; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use; D010627:Phenethylamines / Q000627:therapeutic use*; D005082:Physical Exertion; D010919:Placebos; D012118:Resorcinols / Q000627:therapeutic use*; D012129:Respiratory Function Tests; D012138:Respiratory Therapy; D013997:Time Factors
D000336:Aerosols; D001993:Bronchodilator Agents; D010627:Phenethylamines; D010919:Placebos; D012118:Resorcinols; D009921:Metaproterenol; D007545:Isoproterenol